Диссертация (1174371), страница 19
Текст из файла (страница 19)
2013 Sep 1;88(5):306-10.75.HessH,MietaschikA,135Deichsel G. Drug-induced inhibition ofplatelet function delays progression of peripheral occlusive arterial disease: aprospective double-blind arteriographically controlled trial. Lancet. 1985;1415-41976.Hong YJ, Jeong MH, Lim SY, Lee SR, Kim KH, Sohn IS, Park HW,Kim JH, Kim W, Ahn Y, Cho JG, Park JC, Kang JC. Elevated preprocedural highsensitivity C-reactive protein levels are associated with neointimal hyperplasia andrestenosis development after successful coronary artery stenting.
Circ J. 2005 Dec;69(12):1477-83.77.Ibrahim O, Maskon O, Darinah N, Raymond AA, Rahman MM. Aspirinresistance in patients with acute coronary events: risk factors and prevalence asdetermined by whole blood multiple electrode aggregometry. Pak J Med Sci. 2013Nov;29(6):1319-22.78.Inter-Society Consensus for the Management of Peripheral ArterialDisease (TASC II). Eur J Vasc Endovasc Surg 2007; 33 (Suppl.
1): 1–75.79.Klonaris C, Patelis N, Drebes A, Matheiken S, Liakakos T. Аntiplatelettreatment in peripheral arterial disease: The role of novel antiplatelet agents. CurrPharm Des. 2016 Jun 6.80.Lee C, Nelson PR. Effect of cilostazol prescribed in a pragmatictreatment program for intermittent claudication. Vasc Endovascular Surg. 2014Apr;48(3):224-9.81.Ma-Li Wong, Boxun Xie, Nan Beatini, Phan Phu, Sudhir Marathe,Anthony Johns, Philip W. Gold, Emmet Hirsch, Kevin Jon Williamsi, Julio Licinio,Ira Tabas.
Acute systemic inflammation up-regulates secretory sphingomyelinase invivo: A possible link between inflammatory cytokines and atherogenesis.Proceedings of The National Academy of Sciences - PNAS , vol. 97, no. 15, pp.8681-8686, 200082.Manolis AS1, Tzeis S, Andrikopoulos G, Koulouris S, Melita H. Aspirinand clopidogrel: a sweeping combination in cardiology. Curr Med Chem CardiovascHematol Agents. 2005 Jul;3(3):203-19.83.Mueller MR, Salat A, Stangl136P et al. Variable platelet response to low-dose ASA and the risk of limb deterioration in patients submitted to peripheralarterial angioplasty. Thromb Haemost 1997; 78: 1003–7.84.Neoaortic reconstruction for aortic graft infection: need for endovascularadjunctive therapies? / J.
Faulk [et al.] // Ann. Vasc. Surg. – 2005. – Vol. 19, N 6. –P. 774-781.85.Osada M., Takeda S., Ogawa R., Komori S., Tamura K. T lymphocytesactivation and restenosis after percutaneous transluminal coronary angioplasty. JInterferon Cytokine Res. 2001; 21:219-221.86.Patrono C, Garcia Rodriguez LA, Landolfi R, Baigent C. Low-doseaspirin for the prevention of atherothrombosis. N Engl J Med. 2005;3532373-2383.87.Robertson L, Ghouri MA, Kovacs F. Antiplatelet and anticoagulantdrugs for prevention of restenosis/reocclusion following peripheral endovasculartreatment.
Cochrane Database Syst Rev. 2012 Aug 15;888.Rossi M., Carpi A. Skin microcirculation in peripheral arterialobliterative disease //Biomed. Pharmacother. – 2004. – Oct. – Vol.58(8). – P.427431.89.S. Feld , Y. Almagor, W. Vaugh, M. Leon, P. Serruys. Predictors ofClinical Outcome Following NIR Stent Implantation for Coronary Artery Disease:Analysis of the Results of the First International New Intravascular Rigid-FlexEndovascular Stent Study (FINESS Trial).
Journal of Interventional CardiologyVolume 15, Issue 1, pages 1–6, February 2002.90.Santilli JD, Santilli SM. Chronic critical limb ischemia: diagnosis,treatment and prognosis. University of Minnesota School of Medicine Copyright1999 by the American Academy of Family Physicians.http://www.aafp.org/afp/990401ap/1899.html.91.Schillinger M, Minar E.
Restenosis after percutaneous angioplasty: therole of vascular inflammation. Vasc Health Risk Manag. 2005;1(1):73-8.92.Schillinger M, Percutaneous angioplasty: the role of vascularinflammation in restenosis. Vasc Health Risk Manag. 2005;1(1):73-8.93.Soden PA, Zettervall SL,137Ultee KH, Landon BE, O'Malley AJ,Goodney PP, DeMartino RR, Arya S, Schermerhorn ML. Dual antiplatelet therapy isassociated with prolonged survival after lower extremity revascularization.
Societyfor Vascular Surgery Vascular Quality Initiative. J Vasc Surg. 2015, 36(1):143-9.94.Sottiurai VS. Can intimal hyperplasia and distal anastomotic intimalhyperplasia be controlled and prevented? Ann Vasc Surg. 2007 May;21(3):289-9195.Sullivan TM, Ainsworth SD, Langan EM, Taylor S, Snyder B, Cull D,Youkey J, Laberge M.
Effect of endovascular stent strut geometry on vascular injury,myointimal hyperplasia, and restenosis. J Vasc Surg. 2002 Jul;36(1):143-9.96.Thompson PD, Zimet R, Forbes WP, Zhang P. Meta-analysis of resultsfrom eight randomized, placebo-controlled trials on the effect of cilostazol onpatients with intermittent claudication.
Am J Cardiol. 200297.Thury A, van Langenhove G, Carlier SG, Albertal M, Kozuma K, RegarE, Sianos G, Wentzel JJ, Krams R, Slager CJ, Piek JJ, Serruys PW. High shear stressafter successful balloon angioplasty is associated with restenosis and target lesionrevascularization. Am Heart J. 2002 Jul;144(1):136-43.98.Tjon J.А, Riemann L.E. Treatment of Intermittent Claudication withPentoxifylline and Cilostazol. Am. J. Health– Syst Pharm, 58(6), 485–496, 2001.99.Van Tongeren R.B., Bastiaansen A.J., Van Wissen R.C., Le C.S.,Hamming J.F., Van Bockel J.H. A comparison of the Doppler-derived maximalsystolic acceleration versus the ankle-brachial pressure index or detecting andquantifying peripheral arterial occlusive disease in diabetic patients.
J CardiovascSurg (Torino) 2010; 51: 3: 391—398.100. Vascular allografts are resistant to methicillin-resistant Staphylococcusaureus through indoleamine 2, 3-dioxygenase in a murine model / A. Saito [et al.] // J.Thorac. Cardiovasc. Surg. – 2008. – Vol. 136, N 1. – P. 159-167.101. Vircoulon M, Boulon C, Desormais I, Lacroix P, Aboyans V, BuraRiviere A, Cambou JP, Becker F, Constans J. Comparison of one-year prognosis ofpatients classified as chronic critical lower limb ischaemia according to TASC II orEuropean consensus definition in the COPART cohort. Vasa.
2015 May;44(3):220.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
